IRIS
FEZZA, FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.769
AS - Asia 2.085
EU - Europa 1.779
SA - Sud America 298
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 24.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.702
SG - Singapore 1.005
CN - Cina 431
IT - Italia 282
RU - Federazione Russa 274
UA - Ucraina 258
BR - Brasile 253
DE - Germania 225
HK - Hong Kong 202
IE - Irlanda 183
VN - Vietnam 150
FR - Francia 120
SE - Svezia 101
PL - Polonia 95
GB - Regno Unito 92
BD - Bangladesh 65
FI - Finlandia 61
KR - Corea 61
JP - Giappone 60
CA - Canada 32
IN - India 29
MX - Messico 21
AR - Argentina 19
BE - Belgio 16
ES - Italia 14
ZA - Sudafrica 13
CZ - Repubblica Ceca 12
NL - Olanda 12
EC - Ecuador 10
JM - Giamaica 9
IQ - Iraq 8
TR - Turchia 8
EU - Europa 6
HU - Ungheria 6
ID - Indonesia 6
IL - Israele 6
KG - Kirghizistan 6
VE - Venezuela 6
AU - Australia 5
IR - Iran 5
TH - Thailandia 5
AT - Austria 4
GR - Grecia 4
JO - Giordania 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SC - Seychelles 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 24.976
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.873
Wilmington 5.458
Houston 4.721
Fairfield 673
Singapore 629
Ann Arbor 481
Chandler 370
Ashburn 336
Seattle 272
Jacksonville 247
Cambridge 223
San Jose 222
Hong Kong 196
Beijing 182
Dublin 179
Medford 145
Dearborn 121
Santa Clara 102
New York 89
Los Angeles 84
Kraków 78
The Dalles 72
Lawrence 66
Rome 53
Tokyo 50
Ho Chi Minh City 49
Hanoi 44
Council Bluffs 39
Moscow 39
Mülheim 39
Buffalo 35
Dallas 31
San Diego 30
Menlo Park 28
Munich 28
Lauterbourg 26
São Paulo 26
Milan 23
Chicago 20
Brussels 16
London 16
San Mateo 16
Boardman 15
Warsaw 15
Orem 13
Chennai 12
Verona 12
Brno 11
Zhengzhou 11
Atlanta 10
Columbus 10
Naples 10
Nuremberg 10
Brooklyn 9
Johannesburg 9
Montreal 9
Phoenix 9
Redondo Beach 9
Redwood City 9
Toronto 9
Frankfurt am Main 8
Hefei 8
Seoul 8
Shanghai 8
Cagliari 7
Curitiba 7
Kingston 7
Kunming 7
Mexico City 7
Nanjing 7
Poplar 7
Saint Petersburg 7
San Francisco 7
Boston 6
Detroit 6
Falls Church 6
Fortaleza 6
Palo Alto 6
Rio de Janeiro 6
Berlin 5
Bologna 5
Cangzhou 5
Charlotte 5
Da Nang 5
Denver 5
Guangzhou 5
Helsinki 5
North Bergen 5
Tucson 5
University Park 5
Amman 4
Auburn Hills 4
Baghdad 4
Bari 4
Campinas 4
Catania 4
Dhaka 4
Guayaquil 4
Haiphong 4
Justice 4
Totale 21.845
Salva come PNG Salva come JPEG
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 534
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 515
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 507
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 488
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 484
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 481
Endocannabinoids, related compounds and their metabolic routes 473
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 465
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 463
The anandamide membrane transporter and the therapeutic implications of its inhibition 463
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 462
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 460
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 459
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 456
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 456
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 451
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 450
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 446
Evidence for the intracellular accumulation of anandamide in adiposomes 441
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 439
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 437
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 436
Methods to assay anandamide hydrolysis and transport in synaptosomes. 436
New insights into endocannabinoid degradation and its therapeutic potential 435
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 435
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 434
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 433
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 432
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 430
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 429
Endocannabinoid biochemistry: What do we know after 50 years? 426
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 424
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 422
Endocannabinoids and their involvement in the neurovascular system. 421
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 419
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 419
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 419
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 415
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 415
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 413
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 407
Pitfalls and solutions in assaying anandamide transport in cells. 406
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 398
The endocannabinoid system in neurodegeneration. 398
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 396
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 395
null 393
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 388
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 383
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 378
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 367
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 272
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 221
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 190
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 183
The endocannabinoid hydrolase FAAH is an allosteric enzyme 167
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 160
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 155
Assay of NAPE-PLD Activity 152
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 135
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 126
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 122
Bisphenol A deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin B production 112
Plant-Derived and Endogenous Cannabinoids in Epilepsy 111
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 91
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 84
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 75
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 75
Radiometric Assay of NAPE-PLD Activity 75
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 75
Fatty acid amide hydrolase, anandamide, and neurological diseases 72
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 66
Endocannabinoids and platelets - Signalling pathways 63
Endocannabinoids and platelets - Differentiation 49
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 34
Totale 25.097
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022665 22 80 37 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024230 37 11 11 17 18 55 6 9 10 3 13 40
2024/20251.462 74 348 194 90 25 111 127 72 105 116 133 67
2025/20262.556 213 122 291 205 282 85 314 334 266 191 217 36
Totale 25.097